Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2/3 1

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other 4Gynecologic 1

Conditions

Polycystic Ovary Syndrome 4Obesity 4Prostatic Neoplasms 2Overweight 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Obesity × semaglutide × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT05819853 2025-08-28

RESTORE

University of Colorado, Denver

Phase 3 Recruiting
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting
30 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Peking University First Hospital

Phase 4 Unknown
75 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡